Opinion | Good health care shouldn’t require private donations

Boston Community Pediatrics, a nonprofit Boston practice serving 1,700 largely low-income patients, operated on a $4.8 million budget last year with roughly one-third from insurance reimbursements and two-thirds from philanthropy; 80% of patients are on Medicaid, 40% food insecure and 20% housing insecure. The story highlights the limits of philanthropy to sustain comprehensive primary care, notes Codman Square’s move to a per-patient monthly Medicaid payment model that improved access, and cites Massachusetts data showing commercial insurers spent only 6.7% of health-care dollars on primary care in 2023 with a task force proposing a 15% target and consideration of population-based or single-payer-style primary care funding reforms.

Analysis

Market structure: The article signals a potential policy and payer focus shift from specialty/hospital spend toward primary care — Massachusetts currently spends 6.7% of commercial dollars on primary care and the task force is targeting ~15%, implying a reallocation ~+8.3% of health dollars at the state level. Winners: pure-play value-based primary care platforms, retail clinic operators and Medicaid-focused payers that capture capitated revenue; losers: high-margin specialty procedures and hospital operators that rely on fee-for-service growth. Expect multi-year margin pressure for procedural specialists if other states follow MA’s target.

Competitive dynamics & cross-asset: Moving to population-based PMPM (per-member-per-month) payments increases revenue visibility for primary care and Medicaid MCOs (MOH, CNC) and reduces short-term cash volatility — credit spreads on Medicaid-focused insurers should compress while hospital credits (HCA, UHS) could widen. Clinician supply is the binding constraint: without a 10–20% increase in NP/PCP capacity or telehealth adoption, price for labor will rise, compressing margins for small practices but benefiting scaled platforms and staffing firms. FX/commodities negligible; bonds/options tied to credit moves in insurer/hospital debt.

Risks & timing: Tail risks include political rollback of funding, donor withdrawal (immediate, days–months), or rapid reimbursement cuts to specialists (short-term shock) and workforce shortages (1–3 years) limiting scaling of primary care. Key catalysts: MA legislation outcomes, CMS/Medicaid pilot approvals, and insurer contract language changes in the next 3–12 months. Hidden dependency: success requires operational scalability (EMR, care management)—capital-intensive and time-consuming.

Contrarian & actionable view: The consensus underestimates the investment opportunity in scaled primary-care operators and Medicaid MCOs that already run capitated models; downside risk to hospital equities is underpriced if multiple states emulate MA. If MA or CMS moves materially (approved pilot or 12+ month PMPM increases >20%), expect re-rating of OSH/MOH/CNC within 6–24 months; conversely, philanthropic pullback without policy change would stress small clinics but create M&A opportunities for roll-ups.

Key Decisions for Investors

• Establish a 2–3% long position in Oak Street Health (OSH) over a 6–12 week staggered entry; target +30% in 12–24 months if state/cms capitation pilots expand, set tactical stop-loss at -18% and trim half at +30% gains.
• Add a 1.5–2% position in Molina Healthcare (MOH) as a Medicaid-capitated payer play; prefer 12-month 1x2 call spreads to express upside with limited premium if implied volatility <35%; target +20–30% in 12–18 months.
• Implement a relative-value pair: long OSH (1.5%) / short HCA Healthcare (HCA) (1.0%) to express rotation from hospital fee-for-service to capitated primary care; hedge short with a 9–12 month HCA 10–20% OTM put spread sized to limit max loss to ~1% of portfolio.
• Monitor three catalysts over next 90 days: (1) MA task force bill language and committee votes, (2) any CMS/Medicaid PMPM pilot approvals, (3) Q3–Q4 earnings commentary from UNH/CVS/OAK regarding primary care funding. If any catalyst confirms >20% uplift to primary-care PMPMs, raise OSH/MOH allocation by +50% and add 0.5–1% exposure to telehealth leader (TDOC).